Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prachi Ghule

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 1, 2006
p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastomaPrachi Ghule, Pratibha Amare Kadam, Nirmala Jambhekar, et al.
Archives of Pathology & Laboratory Medicine|December 8, 2006
Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumorsNirmala A Jambhekar, Izhar N Bagwan, Prachi Ghule, et al.
Journal of Cellular Physiology|May 4, 2012
The abbreviated pluripotent cell cycleKristina Kapinas, Rodrigo Grandy, Prachi Ghule, et al.
Current Pharmaceutical Design|March 8, 2012
The architectural organization of human stem cell cycle regulatory machineryGary S Stein, Janet L Stein, Andre van J Wijnen, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
IKAROS Gene Regulatory Network Reveal ERG as a Vulnerability in B-cell Acute Lymphoblastic LeukemiaHana Paculova, Alyssa Richman, Joseph Boyd, et al.
Journal of Cellular Physiology|March 18, 2020
RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cellsAndrew J Fritz, Deli Hong, Joseph Boyd, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2009
The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cyclesRonglin Xie, Ricardo Medina, Ying Zhang, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Acute degron-mediated RUNX1 loss reprograms enhancer activity to epigenetically drive epithelial destabilization and initiate cancer hallmarksAndrew J Fritz, Haley Greenyer, Louis Dillac, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 1, 2006
p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastomaPrachi Ghule, Pratibha Amare Kadam, Nirmala Jambhekar, et al.
Archives of Pathology & Laboratory Medicine|December 8, 2006
Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumorsNirmala A Jambhekar, Izhar N Bagwan, Prachi Ghule, et al.
Journal of Cellular Physiology|May 4, 2012
The abbreviated pluripotent cell cycleKristina Kapinas, Rodrigo Grandy, Prachi Ghule, et al.
Current Pharmaceutical Design|March 8, 2012
The architectural organization of human stem cell cycle regulatory machineryGary S Stein, Janet L Stein, Andre van J Wijnen, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
IKAROS Gene Regulatory Network Reveal ERG as a Vulnerability in B-cell Acute Lymphoblastic LeukemiaHana Paculova, Alyssa Richman, Joseph Boyd, et al.
Journal of Cellular Physiology|March 18, 2020
RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cellsAndrew J Fritz, Deli Hong, Joseph Boyd, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2009
The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cyclesRonglin Xie, Ricardo Medina, Ying Zhang, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Acute degron-mediated RUNX1 loss reprograms enhancer activity to epigenetically drive epithelial destabilization and initiate cancer hallmarksAndrew J Fritz, Haley Greenyer, Louis Dillac, et al.
Pageof 1